Spark Therapeutic, for example cures retinal diseases, genetic mutations, rare diseases, and so we said, Lets try to do this with a drug, or at least a system of a drug thats approved. So we packaged up those three genes, we put them under the control of an antibiotic, doxycyline, and now we could put them into the eye, or anywhere really, and then turn the genes on when we wanted to, to ask the following: if we damage the retina or the optic nerve, and then turn on our reprogramming and make the eye young, well, first of all, does it become young
Characterization of Na + -dependent binding sites of [ 3 H]-glutamate in synaptic membranes from rat brain
Pregnancy in Wilsons disease: management and outcome
Oral BPC157 has been evaluated in models of gastric ulcers, colitis, and gut permeability, where it has shown protective and prohealing effects on the mucosal lining
H., & OConnor, M
This is a bit of an oversimplification, but for a good visual, I often point this out to my patients